The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis

Summary: Compared with SNV&indel-based neoantigens, fusion-based neoantigens are not well characterized. In the present study, we performed a comprehensive analysis of the landscape of tumor fusion neoantigens in cancer and proposed a score scheme to quantitatively assess their immunogenic poten...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Zhiting Wei, Chi Zhou, Zhanbing Zhang, Ming Guan, Chao Zhang, Zhongmin Liu, Qi Liu
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Elsevier 2019-11-01
Cyfres:	iScience
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2589004219304079

Eitemau Tebyg

Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
gan: Chi Zhou, et al.
Cyhoeddwyd: (2020-12-01)

The Neoantigen Landscape of Mycosis Fungoides
gan: Arunima Sivanand, et al.
Cyhoeddwyd: (2020-11-01)

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
gan: Jiefei Han, et al.
Cyhoeddwyd: (2024-02-01)

Integrative pan-cancer landscape of MMS22L and its potential role in hepatocellular carcinoma
gan: Zhiting Guo, et al.
Cyhoeddwyd: (2022-10-01)

Tumor neoantigens and tumor immunotherapies
gan: Wang Jiani, et al.
Cyhoeddwyd: (2024-04-01)

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
gan: Jiaqi Xia, et al.
Cyhoeddwyd: (2021-04-01)

The Role of Neoantigens in Cancer Immunotherapy
gan: Yueting Zhu, et al.
Cyhoeddwyd: (2021-08-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
gan: Zhe Jing, et al.
Cyhoeddwyd: (2022-08-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
gan: Zheying Zhang, et al.
Cyhoeddwyd: (2021-04-01)

Tumor neoantigens: from basic research to clinical applications
gan: Tao Jiang, et al.
Cyhoeddwyd: (2019-09-01)

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy
gan: Jiefei Han, et al.
Cyhoeddwyd: (2025-02-01)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
gan: Manisit Das, et al.
Cyhoeddwyd: (2020-12-01)

Utilization of primary tumor samples for cancer neoantigen discovery
gan: Yong Li, et al.
Cyhoeddwyd: (2025-01-01)

Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
gan: Elisa De Paolis, et al.
Cyhoeddwyd: (2024-12-01)

The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
gan: Chiranjib Chakraborty, et al.
Cyhoeddwyd: (2024-01-01)

Targeting neoantigens for cancer immunotherapy
gan: Xuan Zhao, et al.
Cyhoeddwyd: (2021-07-01)

Pan-cancer landscape of disulfidptosis across human tumors
gan: Kun Fang, et al.
Cyhoeddwyd: (2024-11-01)

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
gan: Stefani Spranger, et al.
Cyhoeddwyd: (2024-11-01)

The tumor therapy landscape of synthetic lethality
gan: Biyu Zhang, et al.
Cyhoeddwyd: (2021-02-01)

The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms
gan: Ping Zhou, et al.
Cyhoeddwyd: (2023-03-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
gan: Wang Wanqiu
Cyhoeddwyd: (2019-01-01)

The Clinical Application of Neoantigens in Esophageal Cancer
gan: Yi-Min Gu, et al.
Cyhoeddwyd: (2021-07-01)

Neoantigens: The Novel Precision Cancer Immunotherapy
gan: Tiantian Zhang, et al.
Cyhoeddwyd: (2023-10-01)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
gan: Alice Newey, et al.
Cyhoeddwyd: (2019-11-01)

Progress in Neoantigen Targeted Cancer Immunotherapies
gan: Xue-Jiao Han, et al.
Cyhoeddwyd: (2020-07-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
gan: Kim Bich Nguyen, et al.
Cyhoeddwyd: (2023-08-01)

Neoantigens: new hope for cancer therapy
gan: Yitong Hu, et al.
Cyhoeddwyd: (2025-03-01)

Identification of BRCA new prognostic targets and neoantigen candidates from fusion genes
gan: Pei Zhang, et al.
Cyhoeddwyd: (2024-12-01)

Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
gan: Guizhi Zhu, et al.
Cyhoeddwyd: (2017-11-01)

Neoantigens: promising targets for cancer therapy
gan: Na Xie, et al.
Cyhoeddwyd: (2023-01-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
gan: Vladimir Roudko, et al.
Cyhoeddwyd: (2020-01-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
gan: Yanwei Shen, et al.
Cyhoeddwyd: (2022-08-01)

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
gan: Yong Qin, et al.
Cyhoeddwyd: (2017-06-01)

Personalised neoantigen‐based therapy in colorectal cancer
gan: Ya‐Juan Zhu, et al.
Cyhoeddwyd: (2023-11-01)

Improvement of Neoantigen Identification Through Convolution Neural Network
gan: Qing Hao, et al.
Cyhoeddwyd: (2021-05-01)

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
gan: Kai Xin, et al.
Cyhoeddwyd: (2024-12-01)

Circular RNA as a source of neoantigens for cancer vaccines
gan: Yi Ren, et al.
Cyhoeddwyd: (2024-03-01)

ALK fusions in the pan-cancer setting: another tumor-agnostic target?
gan: Aditya Shreenivas, et al.
Cyhoeddwyd: (2023-09-01)

Pan-cancer landscape of epigenetic factor expression predicts tumor outcome
gan: Michael W. Cheng, et al.
Cyhoeddwyd: (2023-11-01)

Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
gan: Sadegh Saghafinia, et al.
Cyhoeddwyd: (2018-10-01)